Clinical and Experimental Nephrology

, Volume 18, Issue 2, pp 189–193 | Cite as

Characteristic kidney pathology, gene abnormality and treatments in LCAT deficiency

  • Shuma Hirashio
  • Toshinori Ueno
  • Takayuki Naito
  • Takao Masaki
Review Article WCN 2013 Satellite Symposium ‘‘Kidney and Lipids’’


Lecithin:cholesterol acyltransferase (LCAT) is a key enzyme involved in reverse cholesterol transport from the peripheral tissues to the liver. LCAT deficiency, in which this enzyme is congenitally absent, is a genetic disease that impairs the esterification of free cholesterol in the plasma, leading to accumulation of phospholipids, including lecithin, in the organs of the body; the clinical manifestations include corneal opacities, normochromic anemia, renal disorder, etc. The prognosis is determined by the degree of renal dysfunction, and renal biopsy specimens reveal characteristic light- and electron-microscopic findings. The disease, transmitted by autosomal recessive inheritance, is extremely rare. There have only been 88 gene mutations of the LCAT gene reported around the world, and 13 of them are from Japan. One of the characteristics of LCAT deficiency is the strong correlations among the patterns, extent and phenotypes of these gene mutations.


LCAT deficiency Kidney pathology Gene abnormality Treatments 


  1. 1.
    Glomset JA, Norum KR. The metabolic role of lecithin: cholesterol acyltransferase: perspectives form pathology. Adv Lipid Res. 1973;11:1–65.Google Scholar
  2. 2.
    Gjone E. Familial lecithin:cholesterol acyltransferase deficiency—a new metabolic disease with renal involvement. Adv Nephrol Necker Hosp. 1981;10:167–85.PubMedGoogle Scholar
  3. 3.
    Reichl D, Miller NE. Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism. Arteriosclerosis. 1989;9:785–97.PubMedCrossRefGoogle Scholar
  4. 4.
    Tall AR. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J Clin Invest. 1990;86:379–84.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Norum KR, Gjone E. Familial plasma lecithin: cholesterol acyltransferase deficiency. Scand J Clin Invest. 1967;20:231–43.CrossRefGoogle Scholar
  6. 6.
    Human Gene Mutation Database (2010). (
  7. 7.
    Maruyama T, Yamashita S, Matsuzawa Y, Bujo H, Takahashi K, Saito Y, Ishibashi S, Ohashi K, Shionoiri F, Gotoda T, Yamada N, Kita T. Mutation in Japanese subjects with primary hyperlipidemia (Results from the research committee of the Ministry of Health and Welfare of Japan since 1996. J Atheroscler Thromb. 2004;11:131–45.PubMedCrossRefGoogle Scholar
  8. 8.
    Gjone E. Familial lecithin:cholesterol acyltransferase deficiency—a new metabolic disease with renal involvement. Adv Nephrol Necker Hosp. 1981;10:167–85.PubMedGoogle Scholar
  9. 9.
    Forte T, Norum KR, Glomset JA, Nichols AV. Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: structure of low and high density lipoproteins as revealed by electron microscopy. J Clin Invest. 1971;50:1141–8.PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Hirano K, Kachi S, Ushida C, Naito M. Corneal and macular manifestations in a case of deficient lecithin: cholesterol acyltransferase. Jpn J Ophthalmol. 2004;48:82–4.PubMedCrossRefGoogle Scholar
  11. 11.
    Winder AF, Bron AJ. Lecithin:cholesterol acyl transferase deficiency presenting as visual impairment, with hypocholesterolaemia and normal renal function. Scand J Clin Lab Invest Suppl. 1978;150:151–5.PubMedCrossRefGoogle Scholar
  12. 12.
    Torsvik H. Studies on the protein moiety of serum high density lipoprotein from patients with familial lecithin: cholesterol acyltransferase deficiency. Clin Genet. 1972;3:188–200.PubMedCrossRefGoogle Scholar
  13. 13.
    Vaziri ND, Liang K, Parks JS. Acquired lecithin-cholesterol acyltransferase deficiency in nephrotic syndrome. Am J Physiol Renal Physiol. 2001;280:F823–8.PubMedGoogle Scholar
  14. 14.
    Teisberg P, Gjone E, Olaisen B. Genetics of LCAT (lecithin:cholesterol acyltransferase) deficiency. Ann Hum Genet. 1975;38:327–31.PubMedCrossRefGoogle Scholar
  15. 15.
    Gotoda T, Yamada N, Murase T, Sakuma M, Murayama N, Shimano H, Kozaki K, Albers JJ, Yazaki Y, Akanuma Y. Differential phenotypic expression by three mutant alleles in familial lecithin: cholesterol acyltransferase deficiency. Lancet. 1991;338:778–81.PubMedCrossRefGoogle Scholar
  16. 16.
    Appel GB, Radhakrishnan J, Vilette D. Lecithin-Cholesterol Acyltransferase Dificiency. Brenner and Rector’s The Kidney, 9th Ed. vol 1; 2012. p. 1245–6.Google Scholar
  17. 17.
    Jennette JC, Olson JL, Schwartz MM, Silva FG. Lipid disorders familial lecithin-cholesterol acyl transferase deficiency. heptinstall’s pathology of the kidney 6th Ed. vol 1; 2006. p. 1200–3.Google Scholar
  18. 18.
    Hirashio S, Izumi K, Ueno T, Arakawa T, Naito T, Taguchi T, Yorioka N. Point mutation (C to T) of the LCAT gene resulting in A140C substitution. J Atheroscler Thromb. 2010;17:1297–301.PubMedCrossRefGoogle Scholar
  19. 19.
    Lager DJ, Rosenberg BF, Shapiro H, Bernstein J. Lecithin cholesterol acyltransferase deficiency: ultrastructural examination of sequential renal biopsies. Mod Pathol. 1991;4:331–5.PubMedGoogle Scholar
  20. 20.
    Borysiewicz LK, Soutar AK, Evans DJ, Thompson GR, Rees AJ. Renal failure in familial lecithin: cholesterol acyltransferase deficiency. Q J Med. 1982;51:411–26.PubMedGoogle Scholar
  21. 21.
    Takahashi S, Hiromura K, Tsukida M, Ohishi Y, Hamatani H, Sakurai N, Sakairi T, Ikeuchi H, Kaneko Y, Maeshima A, Kuroiwa T, Yokoo H, Aoki T, Nagata M, Nojima Y. Nephrotic syndrome caused by immune-mediated acquired LCAT deficiency. J Am Soc Nephrol. 2013;24:1305–12.PubMedCrossRefGoogle Scholar
  22. 22.
    Steyrer E, Haubenwallner S, Horl G, GieBauf W, Kostner GM, Zechner R. A single G to A nucleotide transition in exon IV of the lecithin: cholesterol acyltransferase (LCAT) gene results in an Arg to His substitution and causes LCAT deficiency. Hum Genet. 1995;96:105–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Bujo H, Kusunoki J, Ogasawara M, Yamamoto T, Ohta Y, Shimada T, Saito Y, Yoshida S. Molecular defect in familial lecithin:cholesterol acyltransferase (LCAT) deficiency: a single nucleotide insertion in LCAT gene causes a complete deficient type of the disease. Biochem Biophys Res Commun. 1991;181:933–40.PubMedCrossRefGoogle Scholar
  24. 24.
    Miettinen H, Gylling H, Ulmanen I, Miettinen TA, Kontula K. Two different allelic mutations in a Finnish family with lecithin:cholesterol acyltransferase deficiency. Arterioscler Thromb Vasc Biol. 1995;15:460–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Stoekenbroek RM, Van den Bergh Weerman MA, Hovingh GK, Potter van Loon BJ, Siegert CE, Holleboom AG. Familial LCAT deficiency: from renal replacement to enzyme replacement. Neth J Med. 2013;71:29–31.PubMedGoogle Scholar
  26. 26.
    Takata K, Kajiyama G, Horiuchi I, Watanabe T, Tokumo H, Hirata Y. A new case of familial lecithin: cholesterol acyltransferase (LCAT) deficiency–paradoxical findings regarding LCAT mass and activity in 23 members of a family. Jpn J Med. 1989;28:765–71.PubMedCrossRefGoogle Scholar
  27. 27.
    Aranda P, Valdivielso P, Pisciotta L, Garcia I, Garcã A-Arias C, Bertolini S, Martã N-Reyes G, Gonzã Lez-Santos, Calandra S. Therapeutic management of a new case of LCAT deficiency with a multifactorial long-term approach based on high doses of angiotensin II receptor blockers (ARBs). Clin Nephrol. 2008;69:213–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Horina JH, Wirnsberger G, Horn S, Roob JM, Ratschek M, Holzer H, Pogglitsch H, Krejs GJ. Long-term follow-up of a patient with lecithin: cholesterol acyltransferase deficiency syndrome after kidney transplantation. Transplantation. 1993;56:233–6.PubMedCrossRefGoogle Scholar

Copyright information

© Japanese Society of Nephrology 2013

Authors and Affiliations

  • Shuma Hirashio
    • 1
    • 2
  • Toshinori Ueno
    • 1
  • Takayuki Naito
    • 3
  • Takao Masaki
    • 1
  1. 1.Department of NephrologyHiroshima University HospitalHiroshimaJapan
  2. 2.Department of NephrologyNational Hospital Organization Higashihiroshima Medical CenterHigashihiroshimaJapan
  3. 3.Department of NephrologyHiroshima Prefectural HospitalHiroshimaJapan

Personalised recommendations